I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Effectiveness, immunogenicity, and safety of the quadrivale..:
Ivette Maldonado
;
Manuel Plata
;
Mauricio Gonzalez
...
http://dx.doi.org/10.1080/21645515.2022.2078626. , 2022
Link:
https://doi.org/10.1080/21645515.2022.2078626
RT Journal T1
Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:c896750b7beb407cac4a4f28dd301218&Exemplar=1&LAN=DE A1 Ivette Maldonado A1 Manuel Plata A1 Mauricio Gonzalez A1 Alfonso Correa A1 Claudia Nossa A1 Anna R. Giuliano A1 Elmar A. Joura A1 Alex Ferenczy A1 Brigitte M. Ronnett A1 Mark H. Stoler A1 Hao Jin Zhou A1 Amita Joshi A1 Rituparna Das A1 Oliver Bautista A1 Thomas Group A1 Alain Luxembourg A1 Alfred Saah A1 Ulrike Kirsten Buchwald PB Taylor & Francis Group YR 2022 K1 clinical trial K1 effectiveness K1 human papillomavirus K1 immunogenicity K1 mid-adult persons K1 qhpv vaccine K1 Immunologic diseases. Allergy K1 RC581-607 K1 Therapeutics. Pharmacology K1 RM1-950 JF http://dx.doi.org/10.1080/21645515.2022.2078626 LK http://dx.doi.org/https://doi.org/10.1080/21645515.2022.2078626 DO https://doi.org/10.1080/21645515.2022.2078626 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)